ahmed kaseb, md, on combining cabozantinib with checkpoint inhibitors for treatment of hcc
Published 4 years ago • 114 plays • Length 1:24
Download video MP4
Download video MP3
Similar videos
-
2:05
ahmed kaseb, md, on the differentiation of levatinib vs cabozantinib for hcc treatment
-
1:07
ahmed kaseb, md, shares the role of checkpoint inhibitors when alone and combined with anti-ctla4
-
2:27
ahmed kaseb, md, explains the role of immunotherapy in neo-adjuvant treatment of resectable hcc
-
0:43
nevena damjanov, md, on combining cabozantinib with checkpoint inhibitors in advanced hcc patients
-
1:02
ahmed kaseb, md, on survival outcomes in the imbrave 150 phase 3 study
-
11:13
for patients: how cabometyx® (cabozantinib) may work
-
1:16:03
tackling presbyopia
-
4:25
imbrave150 in unresectable hcc
-
1:12
ahmed kaseb, md, elaborates on the phase 1b study investigating atezolizumab bevacizumab in hcc
-
2:50
daneng li, md, on combining cabozantinib with checkpoint inhibitors to improve patient outcomes
-
1:33
richard kim, md, on the combination of cabozantinib & checkpoint inhibitors to improve hcc outcomes
-
1:09
ahmed kaseb, md, considers the effectiveness of bevacizumab atezolizumab in hcc
-
1:57
dr. kaseb on the progression of hcc research
-
2:03
dr. kaseb on research with targeted therapy in hcc
-
1:12
ahmed kaseb, md, offers opinion on nivolumab ipilimumab in resectable hcc
-
0:54
dr. singal on the fda approval of cabozantinib in hcc
-
1:36
cabozantinib in patients with hcc refractory to checkpoint inhibitors
-
0:49
dr. kaseb on safety profile of atezolizumab plus bevacizumab in hcc
-
7:27
cabozantinib plus immune checkpoint inhibitor versus cabozantinib monotherapy in mccrcc
-
30:53
antibiotics aminoglycosides
-
1:18
dr. abou-alfa on the fda approval of cabozantinib in hcc
-
17:17
nivolumab, fluorouracil, and interferon alpha-2b clinical trial - discussion with dr. ahmed kaseb
Clip.africa.com - Privacy-policy